Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00058357Phase 3Completed
A Phase 3 trial of lidocaine in neuropathic pain, sponsored by Cancer and Leukemia Group B. Started May 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00058357.